| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.76B | 43.97B | 40.95B | 37.30B | 30.79B | 36.56B |
| Gross Profit | 13.97B | 13.31B | 13.47B | 12.05B | 8.96B | 11.61B |
| EBITDA | 4.29B | 3.97B | 4.13B | 3.19B | 1.06B | 3.46B |
| Net Income | 3.79B | 3.50B | 2.80B | 601.00M | 1.14B | -217.00M |
Balance Sheet | ||||||
| Total Assets | 43.16B | 45.20B | 41.47B | 41.78B | 36.84B | 36.48B |
| Cash, Cash Equivalents and Short-Term Investments | 8.35B | 10.29B | 9.37B | 8.13B | 6.99B | 7.81B |
| Total Debt | 2.49B | 2.75B | 1.41B | 3.12B | 2.87B | 2.32B |
| Total Liabilities | 12.84B | 14.44B | 13.10B | 16.88B | 13.35B | 13.45B |
| Stockholders Equity | 30.32B | 30.76B | 28.37B | 24.89B | 23.50B | 22.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.68B | 3.13B | 1.30B | -1.33B | 1.55B |
| Operating Cash Flow | 0.00 | 3.27B | 3.74B | 1.73B | -1.07B | 1.90B |
| Investing Cash Flow | 0.00 | -2.81B | -569.00M | -666.00M | 214.00M | -1.09B |
| Financing Cash Flow | 0.00 | 477.00M | -1.97B | 74.00M | 42.00M | -679.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.93B | 71.35 | ― | 4.43% | 0.63% | -24.87% | |
79 Outperform | ¥36.50B | 310.64 | ― | 2.26% | 20.13% | 33.43% | |
70 Outperform | ¥41.62B | 14.45 | ― | 2.93% | -0.90% | -13.24% | |
70 Outperform | ¥219.53B | 6.34 | 12.24% | 2.31% | -2.36% | -61.50% | |
68 Neutral | ¥27.51B | 9.33 | 14.95% | 0.77% | 6.43% | 368.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | ¥4.65B | 44.10 | ― | 2.01% | 13.56% | ― |